Showing results (31-40 of 152) with videos related to
Sort By:
Pageof 16
Immunotherapy Advances|November 29, 2023
DC-targeting lentivectors for cancer immunotherapyEster Gea-Mallorquí, Sarah Rowland-JonesImmunotherapy Advances|August 4, 2023
Establishing a single-sex controlled human Schistosoma mansoni infection model for Uganda: protocol for safety and dose-finding trialAndrew Abaasa, Moses Egesa, Emmanuella Driciru, et al.Immunotherapy Advances|October 16, 2023
Correction to: TIM-3: a tumor-associated antigen beyond checkpoint inhibition?Immunotherapy Advances|July 3, 2023
Treg-based immunotherapy for antigen-specific immune suppression and stable tolerance induction: a perspectiveShimon Sakaguchi, Ryoji Kawakami, Norihisa MikamiImmunotherapy Advances|July 18, 2023
Blockade of innate inflammatory cytokines TNFα, IL-1β, or IL-6 overcomes virotherapy-induced cancer equilibrium to promote tumor regressionMichael J Walsh, Lestat R Ali, Patrick Lenehan, et al.Immunotherapy Advances|September 30, 2022
De-risking clinical trial failure through mechanistic simulationLiam V Brown, Jonathan Wagg, Rachel Darley, et al.Immunotherapy Advances|August 29, 2022
Obesity and adipose tissue impact on T-cell response and cancer immune checkpoint blockade therapyGabriel Pasquarelli-do-Nascimento, Sabrina Azevedo Machado, Juliana Maria Andrade de Carvalho, et al.Immunotherapy Advances|October 26, 2022
Current and future perspectives of chimeric antigen receptors against glioblastomaJosephine Zhang, Jesús A Siller-FarfánImmunotherapy Advances|October 26, 2022
Vitamin D3 replacement enhances antigen-specific immunity in older adultsEmma S Chambers, Milica Vukmanovic-Stejic, Carolin T Turner, et al.Pageof 16